Feng H M, Walker D H
Department of Pathology and WHO Collaborating Center for Tropical Diseases, University of Texas Medical Branch, Galveston, Texas, USA.
Infect Immun. 2000 Dec;68(12):6729-36. doi: 10.1128/IAI.68.12.6729-6736.2000.
The mechanism of killing of obligately intracellular Rickettsia conorii within human target cells, mainly endothelium and, to a lesser extent, macrophages and hepatocytes, has not been determined. It has been a controversial issue as to whether or not human cells produce nitric oxide. AKN-1 cells (human hepatocytes) stimulated by gamma interferon, tumor necrosis factor alpha, interleukin 1beta, and RANTES (regulated by activation, normal T-cell-expressed and -secreted chemokine) killed intracellular rickettsiae by a nitric oxide-dependent mechanism. Human umbilical vein endothelial cells (HUVECs), when stimulated with the same concentrations of cytokines and RANTES, differed in their capacity to kill rickettsiae by a nitric oxide-dependent mechanism and in the quantity of nitric oxide synthesized. Hydrogen peroxide-dependent intracellular killing of R. conorii was demonstrated in HUVECs, THP-1 cells (human macrophages), and human peripheral blood monocytes activated with the cytokines. Rickettsial killing in the human macrophage cell line was also mediated by a limitation of the availability of tryptophan in association with the expression of the tryptophan-degrading enzyme indoleamine-2,3-dioxygenase. The rates of survival of all of the cell types investigated under the conditions of activation and infection in these experiments indicated that death of the host cells was not the explanation for the control of rickettsial infection. This finding represents the first demonstration that activated human hepatocytes and, in some cases, endothelium can kill intracellular pathogens via nitric oxide and that RANTES plays a role in immunity to rickettsiae. Human cells are capable of controlling rickettsial infections intracellularly, the most relevant location in these infections, by one or a combination of three mechanisms involving nitric oxide synthesis, hydrogen peroxide production, and tryptophan degradation.
在人类靶细胞(主要是内皮细胞,其次是巨噬细胞和肝细胞)内,专性细胞内寄生的康氏立克次体的杀灭机制尚未明确。人类细胞是否产生一氧化氮一直是个有争议的问题。γ干扰素、肿瘤坏死因子α、白细胞介素1β和RANTES(受激活调节、正常T细胞表达和分泌的趋化因子)刺激的AKN-1细胞(人肝细胞)通过一氧化氮依赖机制杀灭细胞内立克次体。人脐静脉内皮细胞(HUVECs)在受到相同浓度的细胞因子和RANTES刺激时,通过一氧化氮依赖机制杀灭立克次体的能力以及合成一氧化氮的量有所不同。在HUVECs、THP-1细胞(人巨噬细胞)和用细胞因子激活的人外周血单核细胞中,证实了过氧化氢依赖的细胞内杀灭康氏立克次体的作用。人巨噬细胞系中立克次体的杀灭也由色氨酸可用性的限制介导,这与色氨酸降解酶吲哚胺-2,3-双加氧酶的表达有关。在这些实验中,所有研究的细胞类型在激活和感染条件下的存活率表明,宿主细胞死亡并非控制立克次体感染的原因。这一发现首次证明,激活的人肝细胞以及在某些情况下的内皮细胞可通过一氧化氮杀灭细胞内病原体,且RANTES在对立克次体的免疫中发挥作用。人类细胞能够通过涉及一氧化氮合成、过氧化氢产生和色氨酸降解的三种机制中的一种或多种组合,在细胞内控制立克次体感染,而细胞内感染是这些感染中最相关的部位。